Treatment of these rats with salvianolic acid B inhibited the expression of IL-1β, IL-6, and TNF-α (inflammatory factors) by inhibiting the NF-κB signaling pathway and alleviated intestinal ischemia/reperfusion injury by activating the PI3K/Akt signaling pathway [134]. The gene discussed is NFKB1; the disease is ischemia.